Generate a tailored SOP for Dr. Margit Mahlapuu. Improve your application with a focused, well-structured draft.
Margit Mahlapuu is a Professor at the University of Gothenburg, focusing on the role of GCKIII kinases in metabolic resilience and organ lipotoxicity. Her research investigates the potential therapeutic applications of inhibiting kinases such as STK25 and MST3 in the treatment of metabolic disorders, particularly hepatocellular carcinoma and non-alcoholic fatty liver disease. Over the years, she has made significant contributions through various publications exploring the mechanisms of lipid homeostasis, nerve regeneration, and the effects of nutritional stress on metabolic pathways. She collaborates with numerous research teams, translating her findings into potential advancements in clinical treatments.
University of Gothenburg • Gothenburg, Sweden
Leading research on metabolic diseases and kinase signaling.
Administered by the Department of Political Science; focus on International Administration and Global Governance (IAGG).